Malaria 2007 - Progressing research, persisting challenges

JAMA

Volumn 297, Issue 20, 2007, Pages 2285-2286

  Zuccotti, Gianna ^a   DeAngelis, Catherine D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISIN; ARTESUNATE; FANSIDAR; HEMOGLOBIN VARIANT; QUINIDINE;

BRAIN MALARIA; CHEMOPROPHYLAXIS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG EFFICACY; EDITORIAL; FINANCIAL MANAGEMENT; GENOME ANALYSIS; HETEROZYGOTE; HUMAN; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICATION ERROR; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLICATION; TRAVEL; TREATMENT DURATION; COST OF ILLNESS; DRUG RESISTANCE; HEALTH;

ANTIMALARIALS; BIOMEDICAL RESEARCH; COST OF ILLNESS; DRUG RESISTANCE; HUMANS; MALARIA; WORLD HEALTH;

EID: 34249650291     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.20.2285     Document Type: Editorial

References (18)

1. World Health Organization and UNICEF. World Malaria Report 2005. http: //www.rbm.who.int/wmr2005/. Accessed April 24, 2006.
2. Skarbinski J, James EM, Causer LM, et al. Malaria surveillance in the United States, 2004. MMWR Surveill Summ. 2006;55:23.
3. Feachem RGA, Sabot OJ. Global malaria control in the 21st century: a historic but fleeting opportunity. JAMA. 2007;297:2281-2284.
4. Roll Back Malaria Partnership. Global Strategic Plan: Roll Back Malaria 2005-2015. Geneva, Switzerland: The Global Fund to Fight AIDS, Tuberculosis and Malaria; 2007.
5. Miller JM, Korenromp EL, Nahlen BL, Steketee RW. Estimating the number of insecticide-treated nets required by African households to reach continent-wide malaria coverage targets. JAMA. 2007;297:2241-2250.
6. Hamer DH, Ndhlovu M, Zurovac D, et al. Improved diagnostic testing and malaria treatment practices in Zambia. JAMA. 2007;297:2227-2231.
7. Idro R, Ndiritu M, Ogutu B, et al. Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. JAMA. 2007;297:2232-2240.
8. May J, Evans JA, Timmann C, et al. Hemoglobin variants and disease manifestations in severe falciparum malaria. JAMA. 2007;297:2220-2226.
9. Dorsey G, Staedke S, Clark TD, et al. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA. 2007;297:2210-2219.
10. Leslie T, Mayan MI, Hasan MA, et al. Sulfadoxine-pyrimethamine, chlorproguanildapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial. JAMA. 2007;297:2201-2209.
11. World Health Organization. WHO Guidelines for the Treatment of Malaria. Geneva, Switzerland: WHO Press; 2006. Technical document WHO/HTM/MAL/2006.1108.
12. Chretien J-P, Fukuda M, Noedl H. Improving surveillance for antimalarial drug resistance. JAMA. 2007;297:2278-2281.
13. Griffith KS, Lewis LS, Mali S, Parise ME. Treatment of malaria in the United States: a systematic review. JAMA. 2007;297:2264-2277.
14. Chen LH, Wilson ME, Sclagenhauf P. Controversies and misconceptions in malaria chemoprophylaxis for travelers. JAMA. 2007;297:2251-2263.
15. Jeffares DC, Pain A, Berry A, et al. Genome variation and evolution of the malaria parasite Plasmodium falciparum [correction appears in Nat Genet. 2007;39:422]. Nat Genet. 2007;39:120-125.
16. Mu J, Awadalla P, Duan J, et al. Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome [published online ahead of print December 10, 2006]. Nat Genet. 2007;39:126-130.
17. Volkman SK, Sabeti PC, DeCaprio D, et al. A genome-wide map of diversity in Plasmodium falciparum. Nat Genet. 2007;39:113-119.
18. Friedrich MJ. Malaria researchers target mosquitoes. JAMA. 2007;297:2187.